-Live Mint Incidents at Bhopal and Indore highlight irregularities and ethical violations in some trials In 2004, doctors at the Bhopal Memorial Hospital and Research Centre (BMHRC), established exclusively for treating the victims of the 1984 gas leak, recruited unsuspecting survivors for clinical trials without their knowledge or consent; 14 participants died during the course of the trials. Together with the episode in Indore’s Maharaja Yashwantrao Hospital (that Mint reported on 10...
More »SEARCH RESULT
Total Matching Records found : 516
India's first Japanese encephalitis Vaccine launched
-PTI Pharma firm Biological E Limited (BEL) today launched the country's first indigenous Vaccine to tackle Japanese encephalitis (JE), a deadly viral disease. The Vaccine, JEEV, is priced at Rs. 985. This is a one-time Vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here. "The Vaccine, which will also be exported, has good...
More »Dengue still retains its deadly bite -R Prasad
-The Hindu Vaccine’s overall efficacy in a recent trial is ‘lower than expected’ The just concluded Phase IIb (proof-of-concept) dengue Vaccine trial against all the four virus types (serotypes) that cause dengue has not only shown an unexpectedly low efficacy of 30.2 per cent but has also challenged many well-established hypotheses and ideas. The trial was conducted in about 4,000 children in the age group 4 and 11 in the dengue endemic district...
More »Stepping up pace on the long road to TB control -Virander S Chauhan
-The Hindu Tuberculosis (TB) has remained a major infectious disease in developing and poor countries despite all efforts from health agencies to manage and control it. In fact, even an easy and effective way to diagnose the disease has remained a challenge. Emergence of drug resistant strains has made its management more complex. The steps It makes the situation in countries like India, with the highest TB burden in the world, even more...
More »Government warns PATH -Aarti Dhar
-The Hindu The government has issued a warning letter to Programme for Appropriate Technology in Health (PATH), asking it to be careful while conducting clinical trials so as to ensure that discrepancies and violations are not repeated in future. The Indian Council of Medical Research (ICMR) had suspended the Phase-V post licensure clinical trial being conducted by PATH, an international non-governmental organisation, in Khamman (Andhra Pradesh) and Vadodara (Gujarat) for Human Papilloma...
More »
